Literature DB >> 3495471

Histopathology of intestinal inflammation related to reactive arthritis.

C Cuvelier, C Barbatis, H Mielants, M De Vos, H Roels, E Veys.   

Abstract

This study has identified a group of patients with inflammatory chronic, or relapsing acute arthritis who even in the absence of gastrointestinal symptoms have histological evidence of ileocolitis. At colonoscopy simultaneous biopsies of the terminal ileum and colon were taken from 108 patients with reactive arthritis (n = 55) or ankylosing spondylitis (n = 53), 47 patients with other rheumatic diseases and 19 control patients suffering from colonic polyps, adenocarcinoma, or chronic constipation. All control patients and all but one patient with rheumatoid arthritis, juvenile chronic arthritis, systemic lupus erythematosus, lumbar back ache, and psoriatic arthritis did not have histological evidence of acute or chronic inflammatory bowel disease. In contrast, in 30 of 35 (56.6%) patients with ankylosing spondylitis, and in 37 of 55 (67%) patients with reactive arthritis, regardless of HLA B27 phenotype, there was histological evidence of inflammatory bowel disease with features either of acute enterocolitis, or early Crohn's disease. Only 18 of 67 (27%) of the patients with histological gut inflammation, however, had intestinal symptoms.

Entities:  

Mesh:

Year:  1987        PMID: 3495471      PMCID: PMC1432823          DOI: 10.1136/gut.28.4.394

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  HLA-B27 antigen in diagnosis of atypical seronegative inflammatory arthropathy.

Authors:  G Joliat; A Ferro; M Jeannet; H Ott
Journal:  Ann Rheum Dis       Date:  1976-12       Impact factor: 19.103

2.  Microgranulomas in grossly normal rectal mucosa in Crohn's disease.

Authors:  H Rotterdam; B I Korelitz; S C Sommers
Journal:  Am J Clin Pathol       Date:  1977-06       Impact factor: 2.493

3.  HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease.

Authors:  K Aho; P Ahvonen; A Lassus; K Sievers; A Tiilikainen
Journal:  Arthritis Rheum       Date:  1974 Sep-Oct

4.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

5.  HL-A-W27--a useful discriminator in the arthropathies of inflammatory bowel disease.

Authors:  R I Morris; A L Metzger; R Bluestone; P I Terasaki
Journal:  N Engl J Med       Date:  1974-05-16       Impact factor: 91.245

6.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

7.  Arthritis and Crohn's disease. A family study.

Authors:  I Haslock
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

8.  Arthritis associated with Salmonella infections.

Authors:  C P Warren
Journal:  Ann Rheum Dis       Date:  1970-09       Impact factor: 19.103

9.  An "experimental" epidemic of Reiter's syndrome.

Authors:  H R Noer
Journal:  JAMA       Date:  1966-11-14       Impact factor: 56.272

10.  Yersinia enteritis and enterocolitis: gastroenterological aspects.

Authors:  G Vantrappen; E Ponette; K Geboes; P Bertrand
Journal:  Gastroenterology       Date:  1977-02       Impact factor: 22.682

View more
  40 in total

1.  Stool interleukin 1beta and interleukin 1 receptor antagonist concentrations in children with active ulcerative colitis and during recovery.

Authors:  Andrzej Wedrychowicz; Janina Stopyrowa; Krzysztof Fyderek; Witold Miezynski
Journal:  Eur J Pediatr       Date:  2003-04-26       Impact factor: 3.183

2.  Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.

Authors:  I E A Hoffman; P Demetter; M Peeters; M De Vos; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 3.  The transition of acute to chronic bowel inflammation in spondyloarthritis.

Authors:  Liesbet Van Praet; Peggy Jacques; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2012-04-17       Impact factor: 20.543

4.  Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex.

Authors:  P Demetter; D Baeten; F De Keyser; M De Vos; N Van Damme; G Verbruggen; S Vermeulen; M Mareel; D Elewaut; H Mielants; E M Veys; C A Cuvelier
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

5.  Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides.

Authors:  N Feltelius; S Gudmundsson; L Wennersten; O Sjöberg; R Hällgren; L Klareskog
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

6.  Clinically silent inflammatory gut lesions in undifferentiated spondyloarthropathies.

Authors:  L Altomonte; A Zoli; A Veneziani; L Mirone; G Santacesaria; C Chiarelli; F Federico; G Massi; M Magaro
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

Review 7.  Is the gut intrinsically abnormal in rheumatoid arthritis?

Authors:  A Doube; A J Collins
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

Review 8.  The role of the gut and microbes in the pathogenesis of spondyloarthritis.

Authors:  Mark Asquith; Dirk Elewaut; Phoebe Lin; James T Rosenbaum
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-15       Impact factor: 4.098

Review 9.  Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease?

Authors:  Lode Melis; Dirk Elewaut
Journal:  Arthritis Res Ther       Date:  2009-06-25       Impact factor: 5.156

10.  Linking Crohn's disease and ankylosing spondylitis: it's all about genes!

Authors:  Dirk Elewaut
Journal:  PLoS Genet       Date:  2010-12-02       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.